Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00566670 · ClinicalTrials.gov registry record
Protein, Nutrition and Cardiovascular Disease in Stage 5 Chronic Kidney Disease
A clinical trial of End Stage Renal Disease, sponsored by University of Utah.
- Completed
- Registry status
- 145
- Enrollment target
- 2
- Study locations
NCT00566670: Completed study of End Stage Renal Disease, sponsored by University of Utah.
NCT00566670 is a study of End Stage Renal Disease that has completed, run by University of Utah. The registered enrollment target is 145 participants, below the 832-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (83% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00566670, a study of End Stage Renal Disease, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- 145 participants
- Enrollment target
- 2
- Study locations
Study Summary
National Kidney Foundation guidelines recommend a dietary protein intake of 1.2 grams per kilogram per day (g/kg/d) in hemodialysis patients. However, it is unclear whether consumption of high amounts of protein in dialysis patients has beneficial or harmful nutritional and cardiovascular effects in this population. High protein intake might improve nutritional status, but it has been argued that the state of low muscle mass, small body size and low serum protein levels is not the result of decreased dietary intake, rather a result of hypercatabolism induced by metabolic acidosis, inflammation and oxidative stress. The specific aims of this study are to examine in a prospective cohort of hemodialysis patients the longitudinal associations of absolute total protein intake or dietary protein intake with muscle mass and arterial stiffness.
Primary Outcome
Mid-thigh muscle mass measured by magnetic resonance imaging
Conditions Studied
Study Locations (2)
Tennessee
- Vanderbilt University Medical Centet - Nashville
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 145 participants |
| Start Date | 2007-09 |
| Est. Completion | 2015-10 |
What the finished NCT00566670 record still lists
NCT00566670 is an observational study that tracks outcomes without assigning an intervention. The registered 145 participants enrollment target is mid-sized for trials with a published cap, below the 832-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (83% lower).
The record links to 1 condition, with End Stage Renal Disease appearing as the primary indexed condition, and to 0 interventions.
NCT00566670 reports a single indexed study location in Tennessee, Utah.
Frequently Asked Questions
What is clinical trial NCT00566670 about?
NCT00566670 is a clinical study titled "Protein, Nutrition and Cardiovascular Disease in Stage 5 Chronic Kidney Disease". National Kidney Foundation guidelines recommend a dietary protein intake of 1.2 grams per kilogram per day (g/kg/d) in hemodialysis patients. However, it is unclear whether consumption of high amounts of protein in dialysis patients has beneficial or harmful nutritional and cardiovascular effects in...
What is the current status of trial NCT00566670?
This trial is currently completed. The enrollment target is 145 participants. The study started on 2007-09. Estimated completion is 2015-10.
What conditions does trial NCT00566670 study?
This clinical trial studies the following conditions: End Stage Renal Disease.
Who is sponsoring clinical trial NCT00566670?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00566670 being conducted?
This trial has 2 study locations across Tennessee, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for End Stage Renal Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00566670's enrollment target sits among peer trials
145 28th of 86 higher than 59 of 86 other End Stage Renal Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other End Stage Renal Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
RECRUITING · NA
-
Drug Interaction Potential of Pro-Inflammatory Conditions
RECRUITING
-
PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis
RECRUITING
-
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
RECRUITING · NA
-
AMSC for Reducing Anastomotic Stenosis in Primary Arteriovenous Anastomoses
RECRUITING · Phase 1
-
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02688959 · 145 participants · NA
Motor Attention Training for Attention Deficit Hyperactivity Disorder (ADHD)
- NCT03586609 · 145 participants · Phase 2
Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid Leukemia
- NCT03767595 · 145 participants · NA
ProACT Post-Approval Study
- NCT03808337 · 145 participants · Phase 2
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia